AngioWaveNet vs ASSURE Wearable ECG

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Angiowave Imaging
VS
by Kestra Medical Technologies

AI Verdict

AngioWaveNet is an AI-powered software designed to enhance fluoroscopic angiograms for improved vessel visualization during cardiac catheterization procedures, focusing on optimizing in-procedure diagnostics. In contrast, the ASSURE Wearable ECG offers continuous heart rate monitoring and data collection via a wearable device, primarily for remote patient management and long-term cardiac patient oversight. While both leverage AI within cardiology, they address distinct clinical needs: one for interventional imaging enhancement and the other for remote physiological monitoring.

Choose AngioWaveNet if…

Choose AngioWaveNet if your cardiac catheterization lab requires enhanced, real-time visualization of blood vessels during fluoroscopic angiograms. This AI software is ideal for improving image clarity and detail within existing cath lab workflows, aiding interventional cardiologists in precise diagnostic and therapeutic procedures.

View AngioWaveNet →

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you need continuous, long-term heart rate monitoring and data collection for at-risk cardiac patients outside of a clinical setting. This wearable device is best suited for remote patient monitoring, providing clinicians with automated episode storage and filtered physiological trend data for ongoing cardiac management.

View ASSURE Wearable ECG →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AngioWaveNet ASSURE Wearable ECG
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. Contact for pricing.
Deployment Cloud-based or on-premise/servers Wearable device, mobile application, and cloud-based remote patient data platform.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet is designed for seamless integration into existing Cath lab workflows, offering vendor-agnostic compatibility and functioning as a DICOM endpoint, which minimizes disruption and training for clinical staff. It processes images automatically post-acquisition, allowing clinicians to review both original and enhanced images side-by-side without delaying procedures.

Clinical Value

ASSURE Wearable ECG

While AngioWaveNet improves real-time visualization during procedures, ASSURE Wearable ECG demonstrates a broader and more quantifiable clinical impact. Its continuous monitoring, automatic episode storage, and alert-based notifications have shown 100% successful conversion for VT/VF events and detection of clinically relevant arrhythmias, leading to secondary prevention of sudden cardiac death.

Pricing & Value

AngioWaveNet

AngioWaveNet offers more transparent and flexible pricing models, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs, allowing for better upfront budgeting and value assessment. In contrast, ASSURE Wearable ECG's 'contact for pricing' approach provides less immediate insight into its cost structure.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA-cleared and HIPAA compliant. AngioWaveNet offers flexible cloud or on-premise deployment and vendor-agnostic integration, while ASSURE Wearable ECG explicitly provides a Business Associate Agreement (BAA) and comprehensive security features, crucial for handling patient data in an enterprise setting.

Innovation

ASSURE Wearable ECG

While AngioWaveNet's AI-powered image enhancement is innovative for a mature technology, ASSURE Wearable ECG demonstrates a more comprehensive and disruptive innovation. It integrates advanced wearable hardware, unique SensorFit Garment technology, and sophisticated AI algorithms for continuous, artifact-filtered cardiac monitoring in a mobile environment, extending care beyond traditional clinical settings.

Support & Docs

ASSURE Wearable ECG

ASSURE Wearable ECG explicitly offers 24/7 helpline support for both patients and providers, along with patient handbooks and a dedicated patient application for information, demonstrating a robust and readily accessible support system. AngioWaveNet mentions full onboarding support, including installation assistance, staff training, and access to ongoing updates and clinical resources, but not the same level of continuous, direct patient/provider access.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AngioWaveNet ASSURE Wearable ECG
Name AngioWaveNet ASSURE Wearable ECG
Company Angiowave Imaging Kestra Medical Technologies
Description FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows. A non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Interventional Radiology, Vascular Surgery Cardiology
Key Feature 1 AI-powered Spatiotemporal Enhancement Processing (STEPu2122) Wearable ECG device for continuous heart rate monitoring
Key Feature 2 Improved vessel visualization in fluoroscopic angiograms SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and ASSURE Wearable ECG.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AngioWaveNet is FDA-cleared AI software designed to enhance fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, aiding in interventional procedures. The ASSURE Wearable ECG is a non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients, often used after a Wearable Cardioverter Defibrillator (WCD) prescription.
AngioWaveNet integrates with existing Cath lab workflows, functions as a DICOM endpoint for imaging systems, and is compatible with any fluoroscopic angiography system, making it vendor-agnostic. The ASSURE Wearable ECG integrates through its wearable device, a mobile application, and the Kestra CareStation remote patient data platform for clinician review.
AngioWaveNet provides AI-powered Spatiotemporal Enhancement Processing (STEPu2122) to improve the visibility of blood vessels, vascular structures, and anatomical features in angiographic images. The ASSURE Wearable ECG offers continuous heart rate monitoring, automatic episode storage, alert-based notifications, and physiologic trend data for clinician review.
AngioWaveNet is designed for Cardiology, Interventional Radiology, and Vascular Surgery, focusing on enhancing visualization during angiographic procedures. The ASSURE Wearable ECG is specifically intended for Cardiology, providing continuous heart rate monitoring for at-risk cardiac patients.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.